title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Annexon  ( ANNX )  to Report Q1 Earnings: What's in the Cards?,20240501T141500,https://www.zacks.com/stock/news/2266131/annexon-annx-to-report-q1-earnings-whats-in-the-cards,ALNY,0.137671,Neutral,-0.023677
"Earnings Scheduled For April 28, 2022",20220428T085040,https://www.benzinga.com/news/earnings/22/04/26860440/earnings-scheduled-for-april-28-2022,ALNY,0.014477,Neutral,-0.137174
QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug,20241211T150200,https://www.zacks.com/stock/news/2382224/qure-soars-on-fda-alignment-for-speedy-approval-of-huntingtons-drug,ALNY,0.211191,Neutral,0.066085
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,ALNY,0.134402,Neutral,0.063039
uniQure Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress,20220502T110500,https://www.globenewswire.com/news-release/2022/05/02/2433340/0/en/uniQure-Announces-First-Quarter-2022-Financial-Results-and-Highlights-Recent-Company-Progress.html,ALNY,0.016796,Somewhat-Bullish,0.210379
"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio",20230719T210100,https://www.prnewswire.com/news-releases/hypertension-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---novartis-bayer-merck-insmed-acceleron-abbvie-alnylam--apnimed-astrazeneca-gossamer-bio-301880558.html,ALNY,0.024801,Neutral,0.102776
"Aadi Bioscience, Inc.  ( AADI )  Reports Q4 Loss, Tops Revenue Estimates",20230328T131503,https://www.zacks.com/stock/news/2071261/aadi-bioscience-inc-aadi-reports-q4-loss-tops-revenue-estimates,ALNY,0.2035,Neutral,0.0
